Regulation of antiapoptotic and cytoprotective pathways in colonic epithelial cells in ulcerative colitis

References

• Ordas I, Eckmann L, Talamini M, et al. Ulcerative colitis. Lancet. 2012;380:1606–1619.
   PubMed Web of Science ®Google Scholar
• Langholz E, Munkholm P, Davidsen M, et al. Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol. 1996;31:260–266.
   PubMed Web of Science ®Google Scholar
• Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54.
   PubMed Web of Science ®Google Scholar
• Burisch J, Pedersen N, Cukovi X, et al. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut. 2014;63:588–597.
   PubMed Web of Science ®Google Scholar
• Jess T, Simonsen J, Jorgensen KT, et al. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology. 2012;143:375–381.
   PubMed Web of Science ®Google Scholar
• Jess T, Frisch M, Simonsen J. Trends in overall and cause-specific mortality among patients with inflammatory bowel disease from 1982 to 2010. Clin Gastroenterol Hepatol. 2013;11:43–48.
   PubMed Web of Science ®Google Scholar
• Jess T, Horvath-Puho E, Fallingborg J, et al. Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study. Am J Gastroenterol. 2013;108:1869–1876.
   PubMed Web of Science ®Google Scholar
• Schulzke JD, Ploeger S, Amasheh M, et al. Epithelial tight junctions in intestinal inflammation. Ann N Y Acad Sci. 2009;1165:294–300.
   PubMed Web of Science ®Google Scholar
• Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature. 2011;474:298–306.
   PubMed Web of Science ®Google Scholar
• Thorsteinsdottir S, Gudjonsson T, Nielsen OH, et al. Pathogenesis and biomarkers of carcinogenesis in ulcerative colitis. Nat Rev Gastroenterol Hepatol. 2011;8:395–404.
   PubMed Web of Science ®Google Scholar
• Barker N, van Es JH, Kuipers J, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449:1003–1007.
   PubMed Web of Science ®Google Scholar
• Ritsma L, Ellenbroek SI, Zomer A, et al. Intestinal crypt homeostasis revealed at single-stem-cell level by in vivo live imaging. Nature. 2014;507:362–365.
   PubMed Web of Science ®Google Scholar
• Sato T, Vries RG, Snippert HJ, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009;459:262–265.
   PubMed Web of Science ®Google Scholar
• de Lau W, Barker N, Low TY, et al. Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature. 2011;476:293–U57.
   PubMed Web of Science ®Google Scholar
• Sato T, Stange DE, Ferrante M, et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. Gastroenterology. 2011;141:1762–1772.
   PubMed Web of Science ®Google Scholar
• Barker N, Clevers H. Tracking down the stem cells of the intestine: strategies to identify adult stem cells. Gastroenterology. 2007;133:1755–1760.
   PubMed Web of Science ®Google Scholar
• Schuijers J, Clevers H. Adult mammalian stem cells: the role of Wnt, Lgr5 and R-spondins. EMBO J. 2012;31:2685–2696.
   PubMed Web of Science ®Google Scholar
• Potten CS. Stem cells in gastrointestinal epithelium: numbers, characteristics and death. Philos Trans R Soc Lond, B: Biol Sci. 1998;353:821–830.
   PubMed Web of Science ®Google Scholar
• Sangiorgi E, Capecchi MR. Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet. 2008;40:915–920.
   PubMed Web of Science ®Google Scholar
• Yan KS, Chia LA, Li X, et al. The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations. Proc Natl Acad Sci USA. 2012;109:466–471.
   PubMed Web of Science ®Google Scholar
• Leung C, Lingbeek M, Shakhova O, et al. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature. 2004;428:337–341.
   PubMed Web of Science ®Google Scholar
• Molofsky AV, He S, Bydon M, et al. Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev. 2005;19:1432–1437.
   PubMed Web of Science ®Google Scholar
• Park IK, Qian D, Kiel M, et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature. 2003;423:302–305.
   PubMed Web of Science ®Google Scholar
• Adams JM. Ways of dying: multiple pathways to apoptosis. Genes Dev. 2003;17:2481–2495.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Kepp O, Krautwald S, et al. Molecular mechanisms of regulated necrosis. Semin Cell Dev Biol. 2014;35:24–32.
   PubMed Web of Science ®Google Scholar
• Taddei ML, Giannoni E, Fiaschi T, et al. Anoikis: an emerging hallmark in health and diseases. J Pathol. 2012;226:380–393.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol. 2007;8:931–937.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Vitale I, Abrams JM, et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 2012;19:107–120.
   PubMed Web of Science ®Google Scholar
• Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239–257.
   PubMed Web of Science ®Google Scholar
• Luthi AU, Martin SJ. The CASBAH: a searchable database of caspase substrates. Cell Death Differ. 2007;14:641–650.
   PubMed Web of Science ®Google Scholar
• Green DR. Apoptotic pathways: paper wraps stone blunts scissors. Cell. 2000;102:1–4.
   PubMed Web of Science ®Google Scholar
• Tait SWG, Green DR. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol. 2010;11:621–632.
   PubMed Web of Science ®Google Scholar
• Johansson AC, Appelqvist H, Nilsson C, et al. Regulation of apoptosis-associated lysosomal membrane permeabilization. Apoptosis. 2010;15:527–540.
   PubMed Web of Science ®Google Scholar
• Newton K, Dugger DL, Wickliffe KE, et al. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science. 2014;343:1357–1360.
   PubMed Web of Science ®Google Scholar
• Cai Z, Jitkaew S, Zhao J, et al. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat Cell Biol. 2014;16:55–65.
   PubMed Web of Science ®Google Scholar
• Chen X, Li W, Ren J, et al. Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell Res. 2014;24:105–121.
   PubMed Web of Science ®Google Scholar
• Khan N, Lawlor KE, Murphy JM, et al. More to life than death: molecular determinants of necroptotic and non-necroptotic RIP3 kinase signaling. Curr Opin Immunol. 2014;26:76–89.
   PubMed Web of Science ®Google Scholar
• Subramaniam K, Hirpara JL, Tucker-Kellogg L, et al. FLIP: a flop for execution signals. Cancer Lett. 2013;332:151–155.
   PubMed Web of Science ®Google Scholar
• Czabotar PE, Lessene G, Strasser A, et al. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol. 2014;15:49–63.
   PubMed Web of Science ®Google Scholar
• Li P, Nijhawan D, Budihardjo I, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997;91:479–489.
   PubMed Web of Science ®Google Scholar
• Shimizu S, Narita M, Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature. 1999;399:483–487.
   PubMed Web of Science ®Google Scholar
• Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell. 2004;116:205–219.
   PubMed Web of Science ®Google Scholar
• Hacker G, Weber A. BH3-only proteins trigger cytochrome c release, but how? Arch Biochem Biophys. 2007;462:150–155.
   PubMed Web of Science ®Google Scholar
• Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 2008;9:47–59.
   PubMed Web of Science ®Google Scholar
• Du C, Fang M, Li Y, et al. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell. 2000;102:33–42.
   PubMed Web of Science ®Google Scholar
• Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med. 1989;169:1747–1756.
   PubMed Web of Science ®Google Scholar
• Boldin MP, Goncharov TM, Goltsev YV, et al. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell. 1996;85:803–815.
   PubMed Web of Science ®Google Scholar
• Muzio M, Stockwell BR, Stennicke HR, et al. An induced proximity model for caspase-8 activation. J Biol Chem. 1998;273:2926–2930.
   PubMed Web of Science ®Google Scholar
• Valentijn AJ, Gilmore AP. Translocation of full-length Bid to mitochondria during anoikis. J Biol Chem. 2004;279:32848–32857.
   PubMed Web of Science ®Google Scholar
• Strater J, Hinz U, Walczak H, et al. Expression of TRAIL and TRAIL receptors in colon carcinoma: TRAIL-R1 is an independent prognostic parameter. Clin Cancer Res. 2002;8:3734–3740.
   PubMed Web of Science ®Google Scholar
• Strater J, Moller P. Expression and function of death receptors and their natural ligands in the intestine. Ann N Y Acad Sci. 2000;915:162–170.
   PubMed Web of Science ®Google Scholar
• Iwamoto M, Koji T, Makiyama K, et al. Apoptosis of crypt epithelial cells in ulcerative colitis. J Pathol. 1996;180:152–159.
   PubMed Web of Science ®Google Scholar
• Potten CS, Wilson JW, Booth C. Regulation and significance of apoptosis in the stem cells of the gastrointestinal epithelium. Stem Cells. 1997;15:82–93.
   PubMed Web of Science ®Google Scholar
• Le GM, Chambard JC, Breittmayer JP, et al. The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal. Mol Biol Cell. 2000;11:1103–1112.
   PubMed Web of Science ®Google Scholar
• Qi XJ, Wildey GM, Howe PH. Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function. J Biol Chem. 2006;281:813–823.
   PubMed Web of Science ®Google Scholar
• Pece S, Chiariello M, Murga C, et al. Activation of the protein kinase Akt/PKB by the formation of E-cadherin-mediated cell-cell junctions. Evidence for the association of phosphatidylinositol 3-kinase with the E-cadherin adhesion complex. J Biol Chem. 1999;274:19347–19351.
   PubMed Web of Science ®Google Scholar
• Aoudjit F, Vuori K. Matrix attachment regulates Fas-induced apoptosis in endothelial cells: a role for c-flip and implications for anoikis. J Cell Biol. 2001;152:633–643.
   PubMed Web of Science ®Google Scholar
• Rosen K, Rak J, Leung T, et al. Activated Ras prevents downregulation of Bcl-X(L) triggered by detachment from the extracellular matrix. A mechanism of Ras-induced resistance to anoikis in intestinal epithelial cells. J Cell Biol. 2000;149:447–456.
   PubMed Web of Science ®Google Scholar
• Rosen K, Coll ML, Li A, et al. Transforming growth factor-alpha prevents detachment-induced inhibition of c-Src kinase activity, Bcl-XL down-regulation, and apoptosis of intestinal epithelial cells. J Biol Chem. 2001;276:37273–37279.
   PubMed Web of Science ®Google Scholar
• Loza-Coll MA, Perera S, Shi W, et al. A transient increase in the activity of Src-family kinases induced by cell detachment delays anoikis of intestinal epithelial cells. Oncogene. 2005;24:1727–1737.
   PubMed Web of Science ®Google Scholar
• Toruner M, Fernandez-Zapico M, Sha JJ, et al. Antianoikis effect of nuclear factor-kappaB through up-regulated expression of osteoprotegerin, BCL-2, and IAP-1. J Biol Chem. 2006;281:8686–8696.
   PubMed Web of Science ®Google Scholar
• Vachon PH, Harnois C, Grenier A, et al. Differentiation state-selective roles of p38 isoforms in human intestinal epithelial cell anoikis. Gastroenterology. 2002;123:1980–1991.
   PubMed Web of Science ®Google Scholar
• Grossmann J, Artinger M, Grasso AW, et al. Hierarchical cleavage of focal adhesion kinase by caspases alters signal transduction during apoptosis of intestinal epithelial cells. Gastroenterology. 2001;120:79–88.
   PubMed Web of Science ®Google Scholar
• Strater J, Wedding U, Barth TF, et al. Rapid onset of apoptosis in vitro follows disruption of beta 1-integrin/matrix interactions in human colonic crypt cells. Gastroenterology. 1996;110:1776–1784.
   PubMed Web of Science ®Google Scholar
• Hofmann C, Obermeier F, Artinger M, et al. Cell-cell contacts prevent anoikis in primary human colonic epithelial cells. Gastroenterology. 2007;132:587–600.
   PubMed Web of Science ®Google Scholar
• Grossmann J, Mohr S, Lapentina EG, et al. Sequential and rapid activation of select caspases during apoptosis of normal intestinal epithelial cells. Am J Physiol. 1998;274:G1117–G1124.
   PubMed Web of Science ®Google Scholar
• Levkau B, Herren B, Koyama H, et al. Caspase-mediated cleavage of focal adhesion kinase pp125FAK and disassembly of focal adhesions in human endothelial cell apoptosis. J Exp Med. 1998;187:579–586.
   PubMed Web of Science ®Google Scholar
• Hofmann C, Lippert E, Falk W, et al. Primary human colonic epithelial cells are transiently protected from anoikis by a Src-dependent mechanism. Biochem Biophys Res Commun. 2009;390:908–914.
   PubMed Web of Science ®Google Scholar
• Levine B, Yuan J. Autophagy in cell death: an innocent convict? J Clin Invest. 2005;115:2679–2688.
   PubMed Web of Science ®Google Scholar
• Lum JJ, DeBerardinis RJ, Thompson CB. Autophagy in metazoans: cell survival in the land of plenty. Nat Rev Mol Cell Biol. 2005;6:439–448.
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y, Shimizu S. Another way to die: autophagic programmed cell death. Cell Death Differ. 2005;12:1528–1534.
   PubMed Web of Science ®Google Scholar
• Hampe J, Franke A, Rosenstiel P, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet. 2007;39:207–211.
   PubMed Web of Science ®Google Scholar
• Palomino-Morales RJ, Oliver J, Gomez-Garcia M, et al. Association of ATG16L1 and IRGM genes polymorphisms with inflammatory bowel disease: a meta-analysis approach. Genes Immun. 2009;10:356–364.
   PubMed Web of Science ®Google Scholar
• Cooney R, Baker J, Brain O, et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med. 2010;16:90–97.
   PubMed Web of Science ®Google Scholar
• Travassos LH, Carneiro LA, Ramjeet M, et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol. 2010;11:55–62.
   PubMed Web of Science ®Google Scholar
• Hansson GC. Role of mucus layers in gut infection and inflammation. Curr Opin Microbiol. 2012;15:57–62.
   PubMed Web of Science ®Google Scholar
• Heyman M, Desjeux JF. Cytokine-induced alteration of the epithelial barrier to food antigens in disease. Ann N Y Acad Sci. 2000;915:304–311.
   PubMed Web of Science ®Google Scholar
• Bendfeldt K, Gitter AH, Fromm M. Trans- and paracellular conductivity of HT-29/B6 cells measured by high-resolution conductance scanning. Ann N Y Acad Sci. 1998;859:295–299.
   PubMed Web of Science ®Google Scholar
• Gitter AH, Bendfeldt K, Schmitz H, et al. Epithelial barrier defects in HT-29/B6 colonic cell monolayers induced by tumor necrosis factor-alpha. Ann N Y Acad Sci. 2000;915:193–203.
   PubMed Web of Science ®Google Scholar
• Gitter AH, Bendfeldt K, Schulzke JD, et al. Leaks in the epithelial barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis. FASEB J. 2000;14:1749–1753.
   PubMed Web of Science ®Google Scholar
• Gitter AH, Bendfeldt K, Schulzke JD, et al. Trans/paracellular, surface/crypt, and epithelial/subepithelial resistances of mammalian colonic epithelia. Pflugers Arch. 2000;439:477–482.
   PubMed Web of Science ®Google Scholar
• Riddell RH, Path FRC. Pathology of idiopathic inflammatory bowel disease. In: Kirschner JB, editor. Inflammatory bowel disease. Philadelphia, PE: WB Saunders; 2000. p. 427–450.
   Google Scholar
• Hagiwara C, Tanaka M, Kudo H. Increase in colorectal epithelial apoptotic cells in patients with ulcerative colitis ultimately requiring surgery. J Gastroenterol Hepatol. 2002;17:758–764.
   PubMed Web of Science ®Google Scholar
• Schmitz H, Barmeyer C, Gitter AH, et al. Epithelial barrier and transport function of the colon in ulcerative colitis. Ann N Y Acad Sci. 2000;915:312–326.
   PubMed Web of Science ®Google Scholar
• Gitter AH, Wullstein F, Fromm M, et al. Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging. Gastroenterology. 2001;121:1320–1328.
   PubMed Web of Science ®Google Scholar
• Sandle GI, Higgs N, Crowe P, et al. Cellular basis for defective electrolyte transport in inflamed human colon. Gastroenterology. 1990;99:97–105.
   PubMed Web of Science ®Google Scholar
• Murch SH, Braegger CP, Walker-Smith JA, et al. Distribution and density of TNF immunoreactivity in chronic inflammatory bowel disease. Adv Exp Med Biol. 1995;371B:1327–1330.
   PubMedGoogle Scholar
• Murch SH, Braegger CP, Walker-Smith JA, et al. Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut. 1993;34:1705–1709.
   PubMed Web of Science ®Google Scholar
• Braegger CP, Nicholls S, Murch SH, et al. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet. 1992;339:89–91.
   PubMed Web of Science ®Google Scholar
• Nielsen OH, Gionchetti P, Ainsworth M, et al. Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-alpha in ulcerative colitis. Am J Gastroenterol. 1999;94:2923–2928.
   PubMed Web of Science ®Google Scholar
• Van Antwerp DJ, Martin SJ, Verma IM, et al. Inhibition of TNF-induced apoptosis by NF-kappa B. Trends Cell Biol. 1998;8:107–111.
   PubMed Web of Science ®Google Scholar
• Naujokat C, Sezer O, Possinger K. Tumor necrosis factor-alpha and interferon-gamma induce expression of functional Fas ligand on HT29 and MCF7 adenocarcinoma cells. Biochem Biophys Res Commun. 1999;264:813–819.
   PubMed Web of Science ®Google Scholar
• O'Connell J, Bennett MW, Nally K, et al. Interferon-gamma sensitizes colonic epithelial cell lines to physiological and therapeutic inducers of colonocyte apoptosis. J Cell Physiol. 2000;185:331–338.
   PubMed Web of Science ®Google Scholar
• Xu X, Fu XY, Plate J, et al. IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression. Cancer Res. 1998;58:2832–2837.
   PubMed Web of Science ®Google Scholar
• Ruemmele FM, Russo P, Beaulieu J, et al. Susceptibility to FAS-induced apoptosis in human nontumoral enterocytes: role of costimulatory factors. J Cell Physiol. 1999;181:45–54.
   PubMed Web of Science ®Google Scholar
• Wright K, Kolios G, Westwick J, et al. Cytokine-induced apoptosis in epithelial HT-29 cells is independent of nitric oxide formation. Evidence for an interleukin-13-driven phosphatidylinositol 3-kinase-dependent survival mechanism. J Biol Chem. 1999;274:17193–17201.
   PubMed Web of Science ®Google Scholar
• Breu-Martin MT, Vidrich A, Lynch DH, et al. Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-alpha and ligation of Fas antigen. J Immunol. 1995;155:4147–4154.
   PubMed Web of Science ®Google Scholar
• Sveinbjornsson B, Rushfeldt C, Olsen R, et al. Cytotoxic effect of cytokines on murine colon carcinoma cells involves TNF-mediated apoptosis. Biochem Biophys Res Commun. 1997;233:270–275.
   PubMed Web of Science ®Google Scholar
• Strater J, Wellisch I, Riedl S, et al. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology. 1997;113:160–167.
   PubMed Web of Science ®Google Scholar
• Seminara AR, Ruvolo PP, Murad F. LPS/IFNgamma-induced RAW 264.7 apoptosis is regulated by both nitric oxide-dependent and -independent pathways involving JNK and the Bcl-2 family. Cell Cycle. 2007;6:1772–1778.
   PubMed Web of Science ®Google Scholar
• Li X, McKinstry KK, Swain SL, et al. IFN-gamma acts directly on activated CD4 + T cells during mycobacterial infection to promote apoptosis by inducing components of the intracellular apoptosis machinery and by inducing extracellular proapoptotic signals. J Immunol. 2007;179:939–949.
   PubMed Web of Science ®Google Scholar
• Mebratu YA, Dickey BF, Evans C, et al. The BH3-only protein Bik/Blk/Nbk inhibits nuclear translocation of activated ERK1/2 to mediate IFNgamma-induced cell death. J Cell Biol. 2008;183:429–439.
   PubMed Web of Science ®Google Scholar
• Liu H, Mihara K, Song G, et al. Interferon-gamma attenuates the survival activity of G-CSF through PI3K/Akt signaling pathway in mouse multipotent progenitor cells. Ann Hematol. 2007;86:547–555.
   PubMed Web of Science ®Google Scholar
• Fuss IJ, Neurath M, Boirivant M, et al. Disparate CD4 + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol. 1996;157:1261–1270.
   PubMed Web of Science ®Google Scholar
• Inoue S, Matsumoto T, Iida M, et al. Characterization of cytokine expression in the rectal mucosa of ulcerative colitis: correlation with disease activity. Am J Gastroenterol. 1999;94:2441–2446.
   PubMed Web of Science ®Google Scholar
• Masuda H, Iwai S, Tanaka T, et al. Expression of IL-8, TNF-alpha and IFN-gamma m-RNA in ulcerative colitis, particularly in patients with inactive phase. J Clin Lab Immunol. 1995;46:111–123.
   PubMedGoogle Scholar
• Mankertz J, Schulzke JD. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications. Curr Opin Gastroenterol. 2007;23:379–383.
   PubMed Web of Science ®Google Scholar
• Dignass AU, Baumgart DC, Sturm A. Review article: the aetiopathogenesis of inflammatory bowel disease – immunology and repair mechanisms. Aliment Pharmacol Ther. 2004;20:9–17.
   PubMed Web of Science ®Google Scholar
• Koshiji M, Adachi Y, Sogo S, et al. Apoptosis of colorectal adenocarcinoma (COLO 201) by tumour necrosis factor-alpha (TNF-alpha) and/or interferon-gamma (IFN-gamma), resulting from down-modulation of Bcl-2 expression. Clin Exp Immunol. 1998;111:211–218.
   PubMed Web of Science ®Google Scholar
• Iimura M, Nakamura T, Shinozaki S, et al. Bax is downregulated in inflamed colonic mucosa of ulcerative colitis. Gut. 2000;47:228–235.
   PubMed Web of Science ®Google Scholar
• Begue B, Wajant H, Bambou JC, et al. Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions. Gastroenterology. 2006;130:1962–1974.
   PubMed Web of Science ®Google Scholar
• Brost S, Koschny R, Sykora J, et al. Differential expression of the TRAIL/TRAIL-receptor system in patients with inflammatory bowel disease. Pathol Res Pract. 2010;206:43–50.
   PubMed Web of Science ®Google Scholar
• Blikslager AT, Moeser AJ, Gookin JL, et al. Restoration of barrier function in injured intestinal mucosa. Physiol Rev. 2007;87:545–564.
   PubMed Web of Science ®Google Scholar
• Simmonds NJ, Allen RE, Stevens TR, et al. Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology. 1992;103:186–196.
   PubMed Web of Science ®Google Scholar
• Ahnfelt-Ronne I, Nielsen OH, Christensen A, et al. Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid. Gastroenterology. 1990;98:1162–1169.
   PubMed Web of Science ®Google Scholar
• Seidelin JB, Coskun M, Nielsen OH. Mucosal healing in ulcerative colitis: pathophysiology and pharmacology. Adv Clin Chem. 2013;59:101–123.
   PubMed Web of Science ®Google Scholar
• Karrasch T, Jobin C. NF-kappaB and the intestine: friend or foe? Inflamm Bowel Dis. 2008;14:114–124.
   PubMed Web of Science ®Google Scholar
• Roessner A, Kuester D, Malfertheiner P, et al. Oxidative stress in ulcerative colitis-associated carcinogenesis. Pathol Res Pract. 2008;204:511–524.
   PubMed Web of Science ®Google Scholar
• Seidelin JB, Horn T, Nielsen OH. Simple and efficient method for isolation and cultivation of endoscopically obtained human colonocytes. Am J Physiol Gastrointest Liver Physiol. 2003;285:G1122–G1128.
   PubMed Web of Science ®Google Scholar
• Seidelin JB, Nielsen OH. Attenuated apoptosis response to Fas-ligand in active ulcerative colitis. Inflamm Bowel Dis. 2008;14:1623–1629.
   PubMed Web of Science ®Google Scholar
• Seidelin JB, Nielsen OH. Expression profiling of apoptosis-related genes in enterocytes isolated from patients with ulcerative colitis. Apmis. 2006;114:508–517.
   PubMed Web of Science ®Google Scholar
• Seidelin JB, Vainer B, Andresen L, et al. Upregulation of cIAP2 in regenerating colonocytes in ulcerative colitis. Virchows Arch. 2007;451:1031–1038.
   PubMed Web of Science ®Google Scholar
• Seidelin JB, Coskun M, Vainer B, et al. ERK controls epithelial cell death receptor signalling and cellular FLICE-like inhibitory protein (c-FLIP) in ulcerative colitis. J Mol Med (Berl). 2013;91:839–849.
   PubMed Web of Science ®Google Scholar
• Gyrd-Hansen M, Meier P. IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat Rev Cancer. 2010;10:561–574.
   PubMed Web of Science ®Google Scholar
• Seidelin JB, Jaattela M, Nielsen OH. Continuous interferon-gamma or tumor necrosis factor-alpha exposure of enterocytes attenuates cell death responses. Cytokine. 2004;27:113–119.
   PubMed Web of Science ®Google Scholar
• Seidelin JB, Nielsen OH. Continuous cytokine exposure of colonic epithelial cells induces DNA damage. Eur J Gastroenterol Hepatol. 2005;17:363–369.
   PubMed Web of Science ®Google Scholar
• Seidelin JB, Sträter J, Nielsen OH. Caspase 14 does not influence intestinal epithelial cell differentiation. Cell Death Differ. 2013;20:524
   PubMed Web of Science ®Google Scholar
• Seidelin JB, Bjerrum JT, Coskun M, et al. IL-33 is upregulated in colonocytes of ulcerative colitis. Immunol Lett. 2010;128:80–85.
   PubMed Web of Science ®Google Scholar
• Seidelin JB, Larsen S, Coskun M, et al. Cellular inhibitor of apoptosis protein 2 (cIAP2) controls human colonic epithelial restitution, migration and Rac1 activation. Am J Physiol Gastrointest Liver Physiol. 2015;308:G92–G99.
   PubMed Web of Science ®Google Scholar
• Langholz E, Munkholm P, Davidsen M, et al. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology. 1994;107:3–11.
   PubMed Web of Science ®Google Scholar
• Spiller R. Clinical update: irritable bowel syndrome. Lancet. 2007;369:1586–1588.
   PubMed Web of Science ®Google Scholar
• Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317:1625–1629.
   PubMed Web of Science ®Google Scholar
• Lewis JD, Chuai S, Nessel L, et al. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis. 2008;14:1660–1666.
   PubMed Web of Science ®Google Scholar
• Grossmann J, Walther K, Artinger M, et al. Progress on isolation and short-term ex-vivo culture of highly purified non-apoptotic human intestinal epithelial cells (IEC). Eur J Cell Biol. 2003;82:262–270.
   PubMed Web of Science ®Google Scholar
• Grossmann J, Walther K, Artinger M, et al. Apoptotic signaling during initiation of detachment-induced apoptosis (“anoikis”) of primary human intestinal epithelial cells. Cell Growth Differ. 2001;12:147–155.
   PubMedGoogle Scholar
• Potten CS, Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development. 1990;110:1001–1020.
   PubMed Web of Science ®Google Scholar
• Merritt AJ, Potten CS, Watson AJ, et al. Differential expression of bcl-2 in intestinal epithelia. Correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia. J Cell Sci. 1995;108:2261–2271.
   PubMed Web of Science ®Google Scholar
• Watson AJ, Merritt AJ, Jones LS, et al. Evidence of reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas. Br J Cancer. 1996;73:889–895.
   PubMed Web of Science ®Google Scholar
• Potten CS. Epithelial cell growth and differentiation. II. Intestinal apoptosis. Am J Physiol. 1997;273:G253–G257.
   PubMed Web of Science ®Google Scholar
• Grossmann J, Walther K, Artinger M, et al. Induction of apoptosis before shedding of human intestinal epithelial cells. Am J Gastroenterol. 2002;97:1421–1428.
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63.
   PubMed Web of Science ®Google Scholar
• Stevens MG, Olsen SC. Comparative analysis of using MTT and XTT in colorimetric assays for quantitating bovine neutrophil bactericidal activity. J Immunol Methods. 1993;157:225–231.
   PubMed Web of Science ®Google Scholar
• Zhan Y, van de WB, Wang Y, et al. The roles of caspase-3 and bcl-2 in chemically-induced apoptosis but not necrosis of renal epithelial cells. Oncogene. 1999;18:6505–6512.
   PubMed Web of Science ®Google Scholar
• Nicoletti I, Migliorati G, Pagliacci MC, et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods. 1991;139:271–279.
   PubMed Web of Science ®Google Scholar
• Konorev EA, Kennedy MC, Kalyanaraman B. Cell-permeable superoxide dismutase and glutathione peroxidase mimetics afford superior protection against doxorubicin-induced cardiotoxicity: the role of reactive oxygen and nitrogen intermediates. Arch Biochem Biophys. 1999;368:421–428.
   PubMed Web of Science ®Google Scholar
• Ubezio P, Civoli F. Flow cytometric detection of hydrogen peroxide production induced by doxorubicin in cancer cells. Free Radic Biol Med. 1994;16:509–516.
   PubMed Web of Science ®Google Scholar
• Ostling O, Johanson KJ. Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells. Biochem Biophys Res Commun. 1984;123:291–298.
   PubMed Web of Science ®Google Scholar
• Whitehead RH, Brown A, Bhathal PS. A method for the isolation and culture of human colonic crypts in collagen gels. In Vitro Cell Dev Biol. 1987;23:436–442.
   PubMed Web of Science ®Google Scholar
• Pedersen G, Saermark T, Giese B, et al. A simple method to establish short-term cultures of normal human colonic epithelial cells from endoscopic biopsy specimens. Comparison of isolation methods, assessment of viability and metabolic activity. Scand J Gastroenterol. 2000;35:772–780.
   PubMed Web of Science ®Google Scholar
• Schulzke JD, Bojarski C, Zeissig S, et al. Disrupted barrier function through epithelial cell apoptosis. Ann N Y Acad Sci. 2006;1072:288–299.
   PubMed Web of Science ®Google Scholar
• Seidelin JB, Nielsen OH. Epithelial apoptosis: cause or consequence of ulcerative colitis? Scand J Gastroenterol. 2009;44:1429–1434.
   PubMed Web of Science ®Google Scholar
• Ferreira CG, Span SW, Peters GJ, et al. Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria-controlled manner in the non-small cell lung cancer cell line NCI-H460. Cancer Res. 2000;60:7133–7141.
   PubMed Web of Science ®Google Scholar
• Blanc C, Deveraux QL, Krajewski S, et al. Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells. Cancer Res. 2000;60:4386–4390.
   PubMed Web of Science ®Google Scholar
• Serafini EP, Kirk AP, Chambers TJ. Rate and pattern of epithelial cell proliferation in ulcerative colitis. Gut. 1981;22:648–652.
   PubMed Web of Science ®Google Scholar
• Bleiberg H, Mainguet P, Galand P, et al. Cell renewal in the human rectum. In vitro autoradiographic study on active ulcerative colitis. Gastroenterology. 1970;58:851–855.
   PubMed Web of Science ®Google Scholar
• Beck PL, Rosenberg IM, Xavier RJ, et al. Transforming growth factor-beta mediates intestinal healing and susceptibility to injury in vitro and in vivo through epithelial cells. Am J Pathol. 2003;162:597–608.
   PubMed Web of Science ®Google Scholar
• McKaig BC, Hughes K, Tighe PJ, et al. Differential expression of TGF-beta isoforms by normal and inflammatory bowel disease intestinal myofibroblasts. Am J Physiol Cell Physiol. 2002;282:C172–C182.
   PubMed Web of Science ®Google Scholar
• Babyatsky MW, Rossiter G, Podolsky DK. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology. 1996;110:975–984.
   PubMed Web of Science ®Google Scholar
• Dignass AU, Sturm A. Peptide growth factors in the intestine. Eur J Gastroenterol Hepatol. 2001;13:763–770.
   PubMed Web of Science ®Google Scholar
• Seidelin JB. Colonic epithelial cell turnover: possible implications for ulcerative colitis and cancer initiation. Scand J Gastroenterol. 2004;39:201–211.
   PubMed Web of Science ®Google Scholar
• Martinon F, Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell. 2004;117:561–574.
   PubMed Web of Science ®Google Scholar
• Rothe M, Pan MG, Henzel WJ, et al. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell. 1995;83:1243–1252.
   PubMed Web of Science ®Google Scholar
• Silke J, Meier P. Inhibitor of apoptosis (IAP) proteins-modulators of cell death and inflammation. Cold Spring Harb Perspect Biol. 2013;5:a008730. doi: 10.1101/cshperspect.a008730
   PubMed Web of Science ®Google Scholar
• Deveraux QL, Roy N, Stennicke HR, et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 1998;17:2215–2223.
   PubMed Web of Science ®Google Scholar
• Orth K, Dixit VM. Bik and Bak induce apoptosis downstream of CrmA but upstream of inhibitor of apoptosis. J Biol Chem. 1997;272:8841–8844.
   PubMed Web of Science ®Google Scholar
• Uren AG, Pakusch M, Hawkins CJ, et al. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc Natl Acad Sci USA. 1996;93:4974–4978.
   PubMed Web of Science ®Google Scholar
• Simons M, Beinroth S, Gleichmann M, et al. Adenovirus-mediated gene transfer of inhibitors of apoptosis protein delays apoptosis in cerebellar granule neurons. J Neurochem. 1999;72:292–301.
   PubMed Web of Science ®Google Scholar
• Ruemmele FM, Beaulieu JF, O'Connell J, et al. The susceptibility to Fas-induced apoptosis in normal enterocytes is regulated on the level of cIAP1 and 2. Biochem Biophys Res Commun. 2002;290:1308–1314.
   PubMed Web of Science ®Google Scholar
• Vucic D, Deshayes K, Ackerly H, et al. SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP). J Biol Chem. 2002;277:12275–12279.
   PubMed Web of Science ®Google Scholar
• Liu Z, Sun C, Olejniczak ET, et al. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain. Nature. 2000;408:1004–1008.
   PubMed Web of Science ®Google Scholar
• Srinivasula SM, Hegde R, Saleh A, et al. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature. 2001;410:112–116.
   PubMed Web of Science ®Google Scholar
• Eckelman BP, Salvesen GS. The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J Biol Chem. 2006;281:3254–3260.
   PubMed Web of Science ®Google Scholar
• Huang H, Joazeiro CA, Bonfoco E, et al. The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7. J Biol Chem. 2000;275:26661–26664.
   PubMed Web of Science ®Google Scholar
• Choi YE, Butterworth M, Malladi S, et al. The E3 ubiquitin ligase cIAP1 binds and ubiquitinates caspase-3 and -7 via unique mechanisms at distinct steps in their processing. J Biol Chem. 2009;284:12772–12782.
   PubMed Web of Science ®Google Scholar
• Chu ZL, McKinsey TA, Liu L, et al. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc Natl Acad Sci USA. 1997;94:10057–10062.
   PubMed Web of Science ®Google Scholar
• Wang CY, Mayo MW, Korneluk RG Jr., et al. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 1998;281:1680–1683.
   PubMed Web of Science ®Google Scholar
• Varfolomeev E, Blankenship JW, Wayson SM, et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell. 2007;131:669–681.
   PubMed Web of Science ®Google Scholar
• Blankenship JW, Varfolomeev E, Goncharov T, et al. Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1). Biochem J. 2009;417:149–160.
   PubMed Web of Science ®Google Scholar
• Yang QH, Du C. Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells. J Biol Chem. 2004;279:16963–16970.
   PubMed Web of Science ®Google Scholar
• Fandy TE, Shankar S, Srivastava RK. Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells. Mol Cancer. 2008;7:60
   PubMed Web of Science ®Google Scholar
• Geisbrecht ER, Montell DJ. A role for Drosophila IAP1-mediated caspase inhibition in Rac-dependent cell migration. Cell. 2004;118:111–125.
   PubMed Web of Science ®Google Scholar
• Kim J, Ahn S, Ko YG, et al. Xlinked inhibitor of apoptosis protein controls alpha5-integrin-mediated cell adhesion and migration. Am J Physiol Heart Circ Physiol. 2010;299:H300–H309.
   PubMed Web of Science ®Google Scholar
• Ahn S, Park H. XIAP is essential for shear stress-enhanced Tyr-576 phosphorylation of FAK. Biochem Biophys Res Commun. 2010;399:256–261.
   PubMed Web of Science ®Google Scholar
• Gill C, Dowling C, O'Neill AJ, et al. Effects of cIAP-1, cIAP-2 and XIAP triple knockdown on prostate cancer cell susceptibility to apoptosis, cell survival and proliferation. Mol Cancer. 2009;8:39
   PubMed Web of Science ®Google Scholar
• Sasaki Y, Minamizawa M, Ambo A, et al. Cell-penetrating peptide-conjugated XIAP-inhibitory cyclic hexapeptides enter into Jurkat cells and inhibit cell proliferation. FEBS J. 2008;275:6011–6021.
   PubMed Web of Science ®Google Scholar
• Zarnegar BJ, Wang Y, Mahoney DJ, et al. Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat Immunol. 2008;9:1371–1378.
   PubMed Web of Science ®Google Scholar
• Mahoney DJ, Cheung HH, Mrad RL, et al. Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. Proc Natl Acad Sci USA. 2008;105:11778–11783.
   PubMed Web of Science ®Google Scholar
• Murali A, Rajalingam K. Small Rho GTPases in the control of cell shape and mobility. Cell Mol Life Sci. 2014;71:1703–1721.
   PubMed Web of Science ®Google Scholar
• Hornburger MC, Mayer BA, Leonhardt S, et al. A novel role for inhibitor of apoptosis (IAP) proteins as regulators of endothelial barrier function by mediating RhoA activation. FASEB J. 2014;28:1938–1946.
   PubMed Web of Science ®Google Scholar
• Marivin A, Berthelet J, Cartier J, et al. cIAP1 regulates TNF-mediated cdc42 activation and filopodia formation. Oncogene. 2014;33:5534–5545.
   PubMed Web of Science ®Google Scholar
• Mukaida N, Morita M, Ishikawa Y, et al. Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem. 1994;269:13289–13295.
   PubMed Web of Science ®Google Scholar
• Thiele K, Bierhaus A, Autschbach F, et al. Cell specific effects of glucocorticoid treatment on the NF-kappaBp65/IkappaBalpha system in patients with Crohn's disease. Gut. 1999;45:693–704.
   PubMed Web of Science ®Google Scholar
• Goke MN, Schneider M, Beil W, et al. Differential glucocorticoid effects on repair mechanisms and NF-kappaB activity in the intestinal epithelium. Regul Pept. 2002;105:203–214.
   PubMed Web of Science ®Google Scholar
• Jung S, Fehr S, Harder-d'Heureuse J, et al. Corticosteroids impair intestinal epithelial wound repair mechanisms in vitro. Scand J Gastroenterol. 2001;36:963–970.
   PubMed Web of Science ®Google Scholar
• Landi B, Anh TN, Cortot A, et al. Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gastroenterology. 1992;102:1647–1653.
   PubMed Web of Science ®Google Scholar
• Modigliani R, Mary JY, Simon JF, et al. Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives. Gastroenterology. 1990;98:811–818.
   PubMed Web of Science ®Google Scholar
• Yu JW, Shi Y. FLIP and the death effector domain family. Oncogene. 2008;27:6216–6227.
   PubMed Web of Science ®Google Scholar
• Irmler M, Thome M, Hahne M, et al. Inhibition of death receptor signals by cellular FLIP. Nature. 1997;388:190–195.
   PubMed Web of Science ®Google Scholar
• Hu S, Vincenz C, Ni J, et al. IFLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis. J Biol Chem. 1997;272:17255–17257.
   PubMed Web of Science ®Google Scholar
• Dutton A, Young LS, Murray PG. The role of cellular FLICE inhibitory protein (c-FLIP) in the pathogenesis and treatment of cancer. Expert Opin Ther Targets. 2006;10:27–35.
   PubMed Web of Science ®Google Scholar
• Robinson JM. Reactive oxygen species in phagocytic leukocytes. Histochem Cell Biol. 2008;130:281–297.
   PubMed Web of Science ®Google Scholar
• Nielsen OH. In vitro studies on the significance of arachidonate metabolism and other oxidative processes in the inflammatory response of human neutrophils and macrophages. With special reference to chronic inflammatory bowel disease. Scand J Gastroenterol Suppl. 1988;150:1–21.
   PubMedGoogle Scholar
• Andresen L, Jorgensen VL, Perner A, et al. Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis. Gut. 2005;54:503–509.
   PubMed Web of Science ®Google Scholar
• Perner A, Andresen L, Pedersen G, et al. Superoxide production and expression of NAD(P)H oxidases by transformed and primary human colonic epithelial cells. Gut. 2003;52:231–236.
   PubMed Web of Science ®Google Scholar
• Middleton SJ, Shorthouse M, Hunter JO. Increased nitric oxide synthesis in ulcerative colitis. Lancet. 1993;341:465–466.
   PubMed Web of Science ®Google Scholar
• Boughton-Smith NK, Evans SM, Hawkey CJ, et al. Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet. 1993;342:338–340.
   PubMed Web of Science ®Google Scholar
• Jackson AL, Loeb LA. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res. 2001;477:7–21.
   PubMed Web of Science ®Google Scholar
• Holmes EW, Yong SL, Eiznhamer D, et al. Glutathione content of colonic mucosa: evidence for oxidative damage in active ulcerative colitis. Dig Dis Sci. 1998;43:1088–1095.
   PubMed Web of Science ®Google Scholar
• Koutroubakis IE, Malliaraki N, Dimoulios PD, et al. Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease. Dig Dis Sci. 2004;49:1433–1437.
   PubMed Web of Science ®Google Scholar
• Sakuma I, Stuehr DJ, Gross SS, et al. Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc Natl Acad Sci U.S.A. 1988;85:8664–8667.
   PubMed Web of Science ®Google Scholar
• Kooy NW, Royall JA, Ischiropoulos H. Oxidation of 2',7'-dichlorofluorescin by peroxynitrite. Free Radic Res. 1997;27:245–254.
   PubMed Web of Science ®Google Scholar
• McIlwain DR, Berger T, Mak TW. Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol. 2013;5:a008656
   PubMed Web of Science ®Google Scholar
• Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002;10:417–426.
   PubMed Web of Science ®Google Scholar
• Martinon F, Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ. 2007;14:10–22.
   PubMed Web of Science ®Google Scholar
• Wen H, Miao EA, Ting JP. Mechanisms of NOD-like receptor-associated inflammasome activation. Immunity. 2013;39:432–441.
   PubMed Web of Science ®Google Scholar
• Jarry A, Vallette G, Cassagnau E, et al. Interleukin 1 and interleukin 1beta converting enzyme (caspase 1) expression in the human colonic epithelial barrier. Caspase 1 downregulation in colon cancer. Gut. 1999;45:246–251.
   PubMed Web of Science ®Google Scholar
• Kobori A, Yagi Y, Imaeda H, et al. Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. J Gastroenterol. 2010;45:999–1007.
   PubMed Web of Science ®Google Scholar
• Pastorelli L, Garg RR, Hoang SB, et al. Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis. Proc Natl Acad Sci USA. 2010;107:8017–8022.
   PubMed Web of Science ®Google Scholar
• Beltran CJ, Nunez LE, az-Jimenez D, et al. Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2010;16:1097–1107.
   PubMed Web of Science ®Google Scholar
• Seidelin JB, Rogler G, Nielsen OH. A role for interleukin-33 in T(H)2-polarized intestinal inflammation? Mucosal Immunol. 2011;4:496–502.
   PubMed Web of Science ®Google Scholar
• Iikura M, Suto H, Kajiwara N, et al. IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab Invest. 2007;87:971–978.
   PubMed Web of Science ®Google Scholar
• Ho LH, Ohno T, Oboki K, et al. IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals. J Leukoc Biol. 2007;82:1481–1490.
   PubMed Web of Science ®Google Scholar
• Kroeger KM, Sullivan BM, Locksley RM. IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38{alpha}-dependent pathway. J Leukoc Biol. 2009;86:769–778.
   PubMed Web of Science ®Google Scholar
• Pecaric-Petkovic T, Didichenko SA, Kaempfer S, et al. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood. 2009;113:1526–1534.
   PubMed Web of Science ®Google Scholar
• Ali S, Huber M, Kollewe C, et al. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc Natl Acad Sci USA. 2007;104:18660–18665.
   PubMed Web of Science ®Google Scholar
• Niessner M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol. 1995;101:428–435.
   PubMed Web of Science ®Google Scholar
• Targan SR, Karp LC. Defects in mucosal immunity leading to ulcerative colitis. Immunol Rev. 2005;206:296–305.
   PubMed Web of Science ®Google Scholar
• Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003;3:521–533.
   PubMed Web of Science ®Google Scholar
• Heller F, Florian P, Bojarski C, et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology. 2005;129:550–564.
   PubMed Web of Science ®Google Scholar
• Gachter T, Moritz DR, Gheyselinck J, et al. GATA-dependent expression of the interleukin-1 receptor-related T1 gene in mast cells. Mol Cell Biol. 1998;18:5320–5331.
   PubMed Web of Science ®Google Scholar
• Lohning M, Stroehmann A, Coyle AJ, et al. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci USA. 1998;95:6930–6935.
   PubMed Web of Science ®Google Scholar
• Suzukawa M, Iikura M, Koketsu R, et al. An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J Immunol. 2008;181:5981–5989.
   PubMed Web of Science ®Google Scholar
• Suzukawa M, Koketsu R, Iikura M, et al. Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils. Lab Invest 2008;88:1245–1253.
   PubMed Web of Science ®Google Scholar
• Luthi AU, Cullen SP, McNeela EA, et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity. 2009;31:84–98.
   PubMed Web of Science ®Google Scholar
• Talabot-Ayer D, Lamacchia C, Gabay C, et al. Interleukin-33 is biologically active independently of caspase-1 cleavage. J Biol Chem. 2009;284:19420–19426.
   PubMed Web of Science ®Google Scholar
• Cayrol C, Girard JP. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci USA. 2009;106:9021–9026.
   PubMed Web of Science ®Google Scholar
• Seidelin JB, Coskun M, Kvist PH, et al. IL-33 promotes GATA-3 polarization of gut-derived T cells in experimental and ulcerative colitis. J Gastroenterol. 2014;50:180–190.
   PubMed Web of Science ®Google Scholar
• Sedhom MA, Pichery M, Murdoch JR, et al. Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice. Gut. 2012;62:1714–1723.
   PubMed Web of Science ®Google Scholar
• Palmer G, Talabot-Ayer D, Lamacchia C, et al. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum. 2009;60:738–749.
   PubMed Web of Science ®Google Scholar
• Kearley J, Buckland KF, Mathie SA, et al. Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. Am J Respir Crit Care Med. 2009;179:772–781.
   PubMed Web of Science ®Google Scholar
• Liu X, Li M, Wu Y, et al. Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. Biochem Biophys Res Commun. 2009;386:181–185.
   PubMed Web of Science ®Google Scholar
• Pushparaj PN, Li D, Komai-Koma M, et al. Interleukin-33 exacerbates acute colitis via Interleukin- 4 in mice. Immunology. 2013;140:77.
   Web of Science ®Google Scholar
• Schiering C, Krausgruber T, Chomka A, et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature. 2014;513:564–568.
   PubMed Web of Science ®Google Scholar
• Denecker G, Ovaere P, Vandenabeele P, et al. Caspase-14 reveals its secrets. J Cell Biol. 2008;180:451–458.
   PubMed Web of Science ®Google Scholar
• Denecker G, Hoste E, Gilbert B, et al. Caspase-14 protects against epidermal UVB photodamage and water loss. Nat Cell Biol. 2007;9:666–674.
   PubMed Web of Science ®Google Scholar
• Hoste E, Kemperman P, Devos M, et al. Caspase-14 is required for Filaggrin degradation to natural moisturizing factors in the skin. J Invest Dermatol. 2011;131:2233–2241.
   PubMed Web of Science ®Google Scholar
• Asselin-Labat ML, Sutherland KD, Vaillant F, et al. Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14. Mol Cell Biol. 2011;31:4609–4622.
   PubMed Web of Science ®Google Scholar
• Pistritto G, Jost M, Srinivasula SM, et al. Expression and transcriptional regulation of caspase-14 in simple and complex epithelia. Cell Death Differ. 2002;9:995–1006.
   PubMed Web of Science ®Google Scholar
• Krajewska M, Kim H, Shin E, et al. Tumor-associated alterations in caspase-14 expression in epithelial malignancies. Clin Cancer Res. 2005;11:5462–5471.
   PubMed Web of Science ®Google Scholar
• Ootani A, Li X, Sangiorgi E, et al. Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche. Nat Med. 2009;15:701–706.
   PubMed Web of Science ®Google Scholar
• Beug ST, Cheung HH, LaCasse EC, et al. Modulation of immune signalling by inhibitors of apoptosis. Trends Immunol. 2012;33:535–545.
   PubMed Web of Science ®Google Scholar
• Fulda S. Exploiting inhibitor of apoptosis proteins as therapeutic targets in hematological malignancies. Leukemia. 2012;26:1155–1165.
   PubMed Web of Science ®Google Scholar
• Piao X, Komazawa-Sakon S, Nishina T, et al. cFLIP maintains tissue homeostasis by preventing apoptosis and programmed necrosis. Sci Signal. 2012;5:ra93
   PubMed Web of Science ®Google Scholar
• Wittkopf N, Gunther C, Martini E, et al. Cellular FLICE-like inhibitory protein secures intestinal epithelial cell survival and immune homeostasis by regulating caspase-8. Gastroenterology. 2013;145:1369–1379.
   PubMed Web of Science ®Google Scholar
• Peter ME, Budd RC, Desbarats J, et al. The CD95 receptor: apoptosis revisited. Cell. 2007;129:447–450.
   PubMed Web of Science ®Google Scholar
• Chen JJ, Sun Y, Nabel GJ. Regulation of the proinflammatory effects of Fas ligand (CD95L). Science. 1998;282:1714–1717.
   PubMed Web of Science ®Google Scholar
• Ma Y, Liu H, Tu-Rapp H, et al. Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation. Nat Immunol. 2004;5:380–387.
   PubMed Web of Science ®Google Scholar
• Letellier E, Kumar S, Sancho-Martinez I, et al. CD95-ligand on peripheral myeloid cells activates Syk kinase to trigger their recruitment to the inflammatory site. Immunity. 2010;32:240–252.
   PubMed Web of Science ®Google Scholar